Veramed is pleased to announce the appointment of Anna Hayes as Senior Director for Data Management. With nearly 20 years of experience in the CRO industry, Anna brings a proven track record of leading strategic biometrics partnerships. Her work has consistently helped clients accelerate data reporting and enhance data quality and integrity, always with a focus on scalable, high-impact outcomes.
The appointment of Anna Hayes represents a significant advancement in Veramed’s strategic commitment to strengthening our Data Management function. This key addition to our senior leadership team underscores our continued investment in operational excellence and our dedication to meeting the evolving needs of our clients and expanding portfolio.
“I’m thrilled to join Veramed at such an exciting time of growth and innovation. My goal is to build a scalable, client-focused FSP model that enhances data quality and accelerates timelines. I’ve seen the impact that strong data management can have on clinical success, so I look forward to collaborating with this talented team to drive meaningful impact for our clients and the patients they serve.” Anna Hayes, Senior Director, Data Management.
In this key leadership role, Anna will spearhead our Functional Service Provider (FSP) strategy within Data Management, focusing on delivering flexible, tailored solutions that meet the evolving needs of our clients. Anna is enthusiastic about this new chapter at Veramed and looks forward to shaping the future of clinical data management alongside our talented team.
“Anna’s arrival marks a key step forward in our global data management strategy. With 20 years of experience leading strategic biometrics partnerships, with a strong focus on data quality, scalability, and innovation, her expertise will be instrumental as we expand our FSP model and evolve our data management capabilities to meet the growing complexity of clinical trials. We’re excited to welcome her to Veramed at this pivotal time.” Troy McCall, Chief Executive Officer.
About Veramed
Veramed is a high-performing partner that provides a comprehensive suite of data management and biostatistical services to a global client base. Their team is dedicated to advancing patient health by integrating people, innovation, and technology. The company was verified by Flexa in 2025 as an employer that values flexible work and puts people first. Veramed also demonstrated its commitment to its people, customers and the environment by certifying as a B Corp ™ first in 2020 and again in 2024.
Veramed is passionate about making a difference in patient communities around the world. Being uniquely practitioner-led, the company challenges how advanced biometrics services can be used to help move the needle on the speed, quality, and effectiveness of pharma and biotech pipeline delivery.
